Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1998 | 1 |
1999 | 1 |
2000 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
rongjun ge
(12 results)?
HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes.
Int J Cancer. 2000 Aug 1;87(3):349-59.
Int J Cancer. 2000.
PMID: 10897039
Free article.
Identification of HER2/neu-derived peptide epitopes recognized by gastric cancer-specific cytotoxic T lymphocytes.
Kono K, Rongcun Y, Charo J, Ichihara F, Celis E, Sette A, Appella E, Sekikawa T, Matsumoto Y, Kiessling R.
Kono K, et al.
Int J Cancer. 1998 Oct 5;78(2):202-8. doi: 10.1002/(sici)1097-0215(19981005)78:2<202::aid-ijc14>3.0.co;2-c.
Int J Cancer. 1998.
PMID: 9754653
Free article.
Item in Clipboard
Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas.
Rongcun Y, Salazar-Onfray F, Charo J, Malmberg KJ, Evrin K, Maes H, Kono K, Hising C, Petersson M, Larsson O, Lan L, Appella E, Sette A, Celis E, Kiessling R.
Rongcun Y, et al.
J Immunol. 1999 Jul 15;163(2):1037-44.
J Immunol. 1999.
PMID: 10395702
Item in Clipboard
Cite
Cite